The potential that Electronic Nicotine Delivery Systems can be a disruptive technology: Results from a national survey

Nicotine and Tobacco Research

Volumn 18, Issue 10, 2016, Pages 1989-1997

  Pechacek, Terry F ^a   Nayak, Pratibha ^a   Gregory, Kyle R ^a   Weaver, Scott R ^a   Eriksen, Michael P ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADULT; ARTICLE; AWARENESS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; ELECTRONIC CIGARETTE; FEMALE; HEALTH HAZARD; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; SMOKING CESSATION; SMOKING HABIT; SOCIAL BEHAVIOR; TOBACCO DEPENDENCE; UNITED STATES; YOUNG ADULT; ADOLESCENT; MIDDLE AGED; PREVENTION AND CONTROL; PROCEDURES; PSYCHOLOGY; SATISFACTION; SMOKING; UTILIZATION;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; ELECTRONIC CIGARETTES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NICOTINE; PERSONAL SATISFACTION; SMOKING; SMOKING CESSATION; UNITED STATES; YOUNG ADULT;

EID: 84995639417     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntw102     Document Type: Article

References (80)

1. U.S. Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S Department of Health and Human Services, Centers for Disease Control and Prevention, National Center of Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. www.surgeongeneral.gov/library/reports/50-years-of-progress/full-report. pdf. Accessed November 23 2015.
2. Holford TR, Meza R, Warner KE, et al. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. JAMA. 2014;311(2):164-171. doi:10.1001/jama.2013.285112.
3. Abrams DB. Promise and peril of e-cigarettes: can disruptive technology make cigarettes obsolete? JAMA. 2014;311(2):135-136. doi:10.1001/jama.2013.285347.
4. West R, Brown J. Electronic cigarettes: fact and faction. Br J Gen Pract. 2014;64(626):442-443. doi:10.3399/bjgp14X681253.
5. Hajek P, Etter JF, Benowitz N, Eissenberg T, McRobbie H. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction. 2014;109(11):1801-1810. doi:10.1111/add.12659.
6. Fagerstrom K, Etter J-F, Unger JB. E-cigarettes: a disruptive technology that revolutionizes our field? Nicotine Tob Res. 2015;17(2):125-126. doi:10.1093/ntr/ntu240.
7. Fagerstrom KO, Bridgman K. Tobacco harm reduction: the need for new products that can compete with cigarettes. Addict Behav. 2014;39(3):507-511. doi:10.1016/j.addbeh.2013.11.002.
8. Cobb NK, Abrams DB. The FDA, e-cigarettes, and the demise of combusted tobacco. N Engl J Med. 2014;371(16):1469-1471. doi:10.1056/NEJMp1408448.
9. Sweanor D, Alcabes P, Drucker E. Tobacco harm reduction: how rational public policy could transform a pandemic. Int J Drug Policy. 2007;18(2):70-74. doi:10.1016/j.drugpo.2006.11.013.
10. Caponnetto P, Saitta D, Sweanor D, Polosa R. What to consider when regulating electronic cigarettes: pros, cons and unintended consequences. Int J Drug Policy. 2015;26(6):554-559. doi:http://dx.doi.org/10.1016/j. drugpo.2015.03.001.
11. Bell K, Stimson GV. Nicotine: science, regulation and policy. Int J Drug Policy. 2015;26(6):533-535. doi:10.1016/j.drugpo.2015.04.001.
12. Stimson GV, Thom B, Costall P. Disruptive innovations: the rise of the electronic cigarette. Int J Drug Policy. 2014;25(4):653-655. doi:10.1016/j. drugpo.2014.05.003.
13. Bower JL, Christensen, DM. Disruptive Technologies: Catching the Wave. Harvard Business Review. 1995;73(1):43-53.
14. Christensen M. The Innovator's Solution: Creating and Sustaining Successful Growth. Boston, MA: Harvard Business Press: 2003.
15. Lopez AA, Eissenberg T. Science and the evolving electronic cigarette. Prev Med. 2015;80:101-106. doi:http://dx.doi.org/10.1016/j. ypmed.2015.07.006.
16. Ramôa CP, Hiler MM, Spindle TR, et al. Electronic cigarette nicotine delivery can exceed that of combustible cigarettes: a preliminary report. Tob Control. 2015;25(e1):e6-e9. doi:10.1136/tobaccocontrol-2015-052447.
17. McNeill ABL, Calder R, Hitchman SC, Hajek P, McRobbie H. E-cigarettes: An Evidence Update-A report Commissioned by Public Health England. London, United Kingdom: Public Health England; 2015.
18. Lechner WV, Meier E, Wiener JL, et al. The comparative efficacy of firstversus second-generation electronic cigarettes in reducing symptoms of nicotine withdrawal. Addiction. 2015;110(5):862-867. doi:10.1111/add.12870.
19. Dawkins L, Kimber C, Puwanesarasa Y, Soar K. First-versus secondgeneration electronic cigarettes: predictors of choice and effects on urge to smoke and withdrawal symptoms. Addiction. 2015;110(4):669-677. doi:10.1111/add.12807.
20. Hajek P, Goniewicz ML, Phillips A, et al. Nicotine intake from electronic cigarettes on initial use and after 4 weeks of regular use. Nicotine Tob Res. 2015;17(2):175-179. doi:10.1093/ntr/ntu153.
21. Tan A, Bigman CA. E-cigarette awareness and perceived harmfulness: prevalence and associations with smoking-cessation outcomes. Am J Prev Med. 2014;47(2):141-149.
22. Pepper JK, Brewer NT. Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review. Tob Control. 2014;23(5):375-384. doi:10.1136/tobaccocontrol-2013-051122.
23. Pepper JK, Emery SL, Ribisl KM, Rini CM, Brewer NT. How risky is it to use e-cigarettes? Smokers' beliefs about their health risks from using novel and traditional tobacco products. J Behav Med. 2015;38(2):318-326. doi:10.1007/s10865-014-9605-2.
24. Pepper JK, Ribisl KM, Emery SL, Brewer NT. Reasons for starting and stopping electronic cigarette use. Int J Environ Res Public Health. 2014;11(10):10345-10361. doi:10.3390/ijerph111010345.
25. Harrell PT, Simmons VN, Piñeiro B, et al. E-cigarettes and expectancies: why do some users keep smoking? Addiction. 2015;110(11):1833-1843. doi:10.1111/add.13043.
26. Rass O, Pacek LR, Johnson PS, Johnson MW. Characterizing use patterns and perceptions of relative harm in dual users of electronic and tobacco cigarettes. Exp Clin Psychopharmacol. 2015;23(6):494-503. doi:10.1037/pha0000050.
27. Finney Rutten LJ, Blake KD, Agunwamba AA, et al. Use of E-cigarettes among current smokers: associations among reasons for use, quit intentions, and current tobacco use. Nicotine Tob Res. 2015;17(10):1228-1234. doi:10.1093/ntr/ntv003.
28. Cobb CO, Hendricks PS, Eissenberg T. Electronic cigarettes and nicotine dependence: evolving products, evolving problems. BMC Med. 2015;13:119. doi:10.1186/s12916-015-0355-y.
29. McMillen RC, Gottlieb MA, Shaefer RM, Winickoff JP, Klein JD. Trends in electronic cigarette use among U.S. adults: use is increasing in both smokers and nonsmokers. Nicotine Tob Res. 2015;17(10):1195-1202. doi:10.1093/ntr/ntu213.
30. King BA, Patel R, Nguyen KH, Dube SR. Trends in awareness and use of electronic cigarettes among US adults, 2010-2013. Nicotine Tob Res. 2015;17(2):219-227. doi:10.1093/ntr/ntu191.
31. Regan AK, Promoff G, Dube SR, Arrazola R. Electronic nicotine delivery systems: adult use and awareness of the 'e-cigarette' in the USA. Tob Control. 2013;22(1):19-23. doi:10.1136/tobaccocontrol-2011-050044.
32. Schoenborn CA, Gindi RM. Electronic Cigarette Use Among Adults: United States, 2014. NCHS Data Brief 217. Hyattsville, MD: National Center for Health Statistics; 2015. www.cdc.gov/nchs/data/databriefs/db217.pdf. Accessed January 20, 2016.
33. Delnevo CD, Giovenco DP, Steinberg MB, et al. Patterns of electronic cigarette use among adults in the United States. Nicotine Tob Res. 2016;18(5):715-719. doi:10.1093/ntr/ntv237.
34. Weaver SR, Majeed BA, Pechacek TF, et al. Use of electronic nicotine delivery systems and other tobacco products among USA adults, 2014: results from a national survey. Int J Public Health. 2016;61(2):177-188. doi:10.1007/s00038-015-0761-0.
35. Ward BWSJ, Freeman G, Clarke TC. Early release of selected estimates based on data from the January-June 2015 National Health Interview Survey. 2015. www.cdc.gov/nchs/nhis.htm. Accessed January 20, 2016.
36. Rao JN, Scott AJ. The analysis of categorical data from complex sample surveys: chi-squared tests for goodness of fit and independence in two-way tables. J Am Stat Assoc. 1981;76(374):221-230.
37. Henningfield JE. The tobacco endgame: it's all about behavior. Prev Med. 2014;68:11-16. doi:10.1016/j.ypmed.2014.09.003.
38. Brose LS, Brown J, Hitchman SC, McNeill A. Perceived relative harm of electronic cigarettes over time and impact on subsequent use. A survey with 1-year and 2-year follow-ups. Drug Alcohol Depend. 2015;157:106-111. doi:http://dx.doi.org/10.1016/j.drugalcdep.2015.10.014.
39. Brose LS, Hitchman SC, Brown J, West R, McNeill A. Is the use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption? A survey with a 1-year follow-up. Addiction. 2015;110(7):1160-1168. doi:10.1111/add.12917.
40. Hitchman SC, Brose LS, Brown J, Robson D, McNeill A. Associations between e-cigarette type, frequency of use, and quitting smoking: findings from a longitudinal online panel survey in Great Britain. Nicotine Tob Res. 2015;17(10):1187-1194. doi:http://ezproxy.gsu.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=mnh&AN=25896067 &site=ehost-live&scope=site.
41. McNeill A, Brose LS, Calder R, et al. E-cigarettes: the need for clear communication on relative risks. Lancet. 2015;386(10000):1237. doi:10.1016/S0140-6736(15)00079-3.
42. Hitchman SC, McNeill A, Brose LS. Electronic cigarettes: time for an accurate and evidence-based debate. Addiction. 2014;109(6):867-868. doi:10.1111/add.12550.
43. Huang J, Tauras J, Chaloupka FJ. The impact of price and tobacco control policies on the demand for electronic nicotine delivery systems. Tobacco Control. 2014;23(suppl 3): iii41-iii47. doi:10.1136/tobaccocontrol-2013-051515.
44. Chaloupka FJ, Sweanor D, Warner KE. Differential taxes for differential risks-toward reduced harm from nicotine-yielding products. N Engl J Med. 2015;373(7):594-597. doi:doi:10.1056/NEJMp1505710.
45. Cummings KM, Morley CP, Horan JK, Steger C, Leavell N-R. Marketing to America's youth: evidence from corporate documents. Tob Control. 2002;11(suppl 1): i5-i17. doi:10.1136/tc.11.suppl_1.i5.
46. Hatsukami DK. Ending tobacco-caused mortality and morbidity: the case for performance standards for tobacco products. Tob Control. 2013;22(suppl 1):i36-i37. doi:10.1136/tobaccocontrol-2012-050785.
47. Donny EC, Hatsukami DK, Benowitz NL, et al. Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation. Prev Med. 2014;68:17-22. doi:10.1016/j.ypmed.2014.06.020.
48. Husten CG, Deyton LR. Understanding the Tobacco Control Act: efforts by the US Food and Drug Administration to make tobacco-related morbidity and mortality part of the USA's past, not its future. Lancet. 2013;381(9877):1570-1580. doi:10.1016/S0140-6736(13)60735-7.
49. Azagba S, Sharaf MF. The effect of graphic cigarette warning labels on smoking behavior: evidence from the Canadian experience. Nicotine Tob Res. 2013;15(3):708-717. doi:10.1093/ntr/nts194.
50. Huang J, Chaloupka FJ, Fong GT. Cigarette graphic warning labels and smoking prevalence in Canada: a critical examination and reformulation of the FDA regulatory impact analysis. Tob Control. 2014; 23(suppl 1): i7-12. doi:10.1136/tobaccocontrol-2013-051170.
51. Hammond D. Health warning messages on tobacco products: a review. Tob Control. 2011;20(5):327-337. doi:10.1136/tc.2010.037630.
52. McAfee T, Davis KC, Alexander RL, Pechacek TF, Bunnell R. Effect of the first federally funded US antismoking national media campaign. Lancet. 2013;382(9909):2003-2011. doi:10.1016/s0140-6736(13)61686-4.
53. Wakefield MA, Durkin S, Spittal MJ, et al. Impact of tobacco control policies and mass media campaigns on monthly adult smoking prevalence. Am J Public Health. 2008;98(8):1443-1450. doi:10.2105/AJPH.2007.128991.
54. Malone RE. Imagining things otherwise: new endgame ideas for tobacco control. Tob Control. 2010;19(5):349-350. doi:10.1136/tc.2010.039727.
55. McDaniel PA, Smith EA, Malone RE. The tobacco endgame: a qualitative review and synthesis [published online ahead of print August 28, 2015]. Tob Control. 2015. doi:10.1136/tobaccocontrol-2015-052356.
56. Malone RE. Tobacco endgames: what they are and are not, issues for tobacco control strategic planning and a possible US scenario. Tob Control. 2013;22(suppl 1): i42-i44. doi:10.1136/tobaccocontrol-2012-050820.
57. World Health Organization. Plain Packaging of Tobacco Products: Measures to Decrease Smoking Initiation and Increase Cessation. Copenhagen, Denmark: World Health Organization, Regional Office for Europe; 2014. www.euro.who.int/__data/assets/pdf_file/0011/268796/Plain-packaging-oftobacco-products,-Evidence-Brief-Eng.pdf?ua=1. Accessed August 20 2015.
58. Bonnie RJ, Stratton K, Kwan LY. Public Health Implications of Raising the Minimum Age of Legal Access to Tobacco Products. Washington, DC: Institute of Medicine, National Academies Press (US); 2015.
59. Winickoff JP, Hartman L, Chen ML, et al. Retail impact of raising tobacco sales age to 21 years. Am J Public Health. 2014;104(11):e18-e21. doi:10.2105/AJPH.2014.302174.
60. Shang C, Chaloupka FJ, Fong GT, Thompson M, O'Connor RJ. The association between tax structure and cigarette price variability: findings from the International Tobacco Control Policy Evaluation (ITC) Project. Tob Control. 2015;24(3):iii88-iii93. doi:10.1136/tobaccocontrol-2014-051771.
61. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation. 2014;129(19):1972-1986. doi:10.1161/CIRCULATIONAHA.114.007667.
62. Chen I-L, Husten CG. Introduction to tobacco control supplement. Tob Control. 2014;23(suppl 2):ii1-ii3. doi:10.1136/tobaccocontrol-2013-051504.
63. Schraufnagel DE, Blasi F, Drummond MB, et al. Electronic cigarettes. A position statement of the forum of international respiratory societies. Am J Respir Crit Care Med. 2014;190(6):611-618. doi:10.1164/rccm.201407-1198PP.
64. Franck C, Budlovsky T, Windle SB, Filion KB, Eisenberg MJ. Electronic cigarettes in North America: history, use, and implications for smoking cessation. Circulation. 2014;129(19):1945-1952. doi:10.1161/CIRCULATIONAHA.113.006416.
65. Tremblay MC, Pluye P, Gore G, et al. Regulation profiles of e-cigarettes in the United States: a critical review with qualitative synthesis. BMC Med. 2015;13:130. doi:10.1186/s12916-015-0370-z.
66. Thomas BP, Gostin LO. Tobacco endgame strategies: challenges in ethics and law. Tob Control. 2013;22(suppl 1):i55-i57. doi:10.1136/tobaccocontrol-2012-050839.
67. Zeller M. Three years later: an assessment of the implementation of the Family Smoking Prevention and Tobacco Control Act. Tob Control. 2012;21(5):453-454. doi:10.1136/tobaccocontrol-2012-050680.
68. Pisinger C, Dossing M. A systematic review of health effects of electronic cigarettes. Prev Med. 2014;69:248-260. doi:10.1016/j.ypmed.2014.10.009.
69. Food and Drug Administration. Deeming tobacco products to be subject to the federal food, drug, and cosmetic act, as amended by the Family Smoking Prevention and Tobacco Control Act; Regulations on the sale and distribution of tobacco products and required warning statements for tobacco products. Silver Spring, MD: Department of Health and Human Services, Food and Drug Administration; 2014. www.federalregister. gov/articles/2014/04/25/2014-09491/deeming-tobacco-products-to-besubject-to-the-federal-food-drug-and-cosmetic-act-as-amended-by-the. Accessed December 11 2015.
70. The Lancet O. Time for e-cigarette regulation. Lancet Oncol. 2013;14(11):1027. doi:10.1016/s1470-2045(13)70468-6.
71. Fairchild AL, Bayer R. Public health. Smoke and fire over e-cigarettes. Science. 2015;347(6220):375-376. doi:10.1126/science.1260761.
72. Kaufman N, Mahoney M. E-cigarettes: policy options and legal issues amidst uncertainty. J Law Med Ethics. 2015;43(suppl 1):23-26. doi:10.1111/jlme.12209.
73. Kalkhoran S, Glantz SA. Modeling the health effects of expanding e-cigarette sales in the United States and United Kingdom: a Monte Carlo Analysis. JAMA Intern Med. 2015;175(10):1671-1680. doi:10.1001/jamainternmed.2015.4209.
74. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Resp Med. 2016;4(2):116-128. doi:10.1016/S2213-2600(15)00521-4.
75. Vugrin ED, Rostron BL, Verzi SJ, et al. Modeling the potential effects of new tobacco products and policies: a dynamic population model for multiple product use and harm. PLoS One. 2015;10(3):e0121008. doi:10.1371/journal.pone.0121008.
76. Ambrose BK, Day HR, Rostron B, et al. Flavored tobacco product use among US youth aged 12-17 years, 2013-2014. JAMA. 2015;314(17):1871-1873. doi:10.1001/jama.2015.13802.
77. Dennis MJ, Cobb CL, Peugh J, Lawrence M. The Prevalence and Impact of Self-Selection Bias and Panel Conditioning on Smoker Studies Using Established Internet Panels. Paper presented at the American Association for Public Opinion Research; 2013; Boston, MA.
78. Caraballo RS, Giovino GA, Pechacek TF. Self-reported cigarette smoking vs. serum cotinine among U.S. adolescents. Nicotine Tob Res. 2004;6(1):19-25. doi:10.1080/14622200310001656821.
79. Pisinger C. Why public health people are more worried than excited over e-cigarettes. BMC Medicine. 2014;12:226-226. doi:10.1186/s12916-014-0226-y.
80. Agaku IT, King BA, Husten CG, et al. Tobacco product use among adults-United States, 2012-2013. MMWR Morb Mortal Wkly Rep. 2014;63(25):542-547. doi:http://www.ncbi.nlm.nih.gov/pubmed/24964880.